RDUS Radius Health Inc.

-0.37  -2%
Previous Close 20.79
Open 20.65
Price To Book 33.48
Market Cap 941512761
Shares 46,107,383
Volume 210,070
Short Ratio
Av. Daily Volume 601,568

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 3 trial initiation announced March 31, 2018.
TYMLOS Abaloparatide-SC
Male Osteoporosis
Phase 3 data 2021.
Elacestrant - EMERALD
Breast cancer
PDUFA date originally scheduled for March 30 2017 delayed by three months to June 30, 2017. Approval announced April 28, 2017.
TYMLOS (Abaloparatide)
Phase 1 dose-expansion cohort to be initiated mid-2019.
Solid tumors
Phase 3 trial to be initiated August 2019.
Abaloparatide -Transdermal Patch
Phase 1 trial presentation at SABCS December 2018.
Breast cancer

Latest News

  1. Edited Transcript of RDUS earnings conference call or presentation 8-May-19 12:00pm GMT
  2. Radius Health to Present at Bank of America Merrill Lynch Health Care Conference 2019
  3. Radius Health (RDUS) Q1 2019 Earnings Call Transcript
  4. Radius (RDUS) Posts Narrower Q1 Loss, Misses on Revenues
  5. Here’s What Hedge Funds Think About Radius Health Inc (RDUS)
  6. Radius Health (RDUS) Reports Q1 Loss, Lags Revenue Estimates
  7. Radius Health Announces First Quarter 2019 Operating Results
  8. Radius Health: 1Q Earnings Snapshot
  9. See what the IHS Markit Score report has to say about Radius Health Inc.
  10. Small Drug Stocks Outlook: Near-Term Prospects Encouraging
  11. Will Radius Health (RDUS) Report Negative Earnings Next Week? What You Should Know
  12. Have Insiders Been Buying Radius Health, Inc. (NASDAQ:RDUS) Shares?
  13. Radius Health to Announce First Quarter 2019 Financial Results, Host Conference Call and Live Webcast on Wednesday, May 8, 2019
  14. Edited Transcript of RDUS earnings conference call or presentation 28-Feb-19 9:30pm GMT
  15. Radius Health to Present Two Posters at AACE 2019 Annual Meeting
  16. Radius Health (RDUS) Rallies 33.4% YTD on Robust Tymlos Sales
  17. Amgen's (AMGN) Osteoporosis Drug Evenity Gets FDA Approval
  18. Why Is Radius Health (RDUS) Up 5.2% Since Last Earnings Report?
  19. Detailed Research: Economic Perspectives on General Mills, Archrock, Crocs, Monolithic Power, Radius Health, and Gibraltar Industries — What Drives Growth in Today's Competitive Landscape